U.S. flag An official website of the United States government
  1. Home
  2. Vaccines, Blood & Biologics
  3. Cellular & Gene Therapy Products
  4. BREYANZI (lisocabtagene maraleucel)
  1. Cellular & Gene Therapy Products

BREYANZI (lisocabtagene maraleucel)

STN# BLA 125714
Proper Name:  lisocabtagene maraleucel
Tradename: BREYANZI
Manufacturer: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company


  • For the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, including diffuse large B-cell lymphoma (DLBCL) not otherwise specified (including DLBCL arising from indolent lymphoma), high-grade B-cell lymphoma, primary mediastinal large B-cell lymphoma, and follicular lymphoma grade 3B.

Product Information

Supporting Documents

Back to Top